In deep vein thrombosis (DVT) of the lower limb, the location of the thrombosis determines how great the risk of pulmonary embolism is. We set out to determine whether the duration of lower limb DVT symptoms could be a predictive factor for the location of the thrombosis. We retrospectively collected a series of 100 lower limb phlebography examinations that were positive for DVT and divided the group into 2 subgroups proximal disease (ie, above the knee) or distal disease (ie, below the knee). The subgroups were then plotted against the individual duration of the symptoms. Of the 100 DVTs, 58% were proximal, while 42% were distal. The average duration of the symptoms was 6.3 days for patients with proximal disease and 6.2 days for patients with distal disease. We, therefore, found no difference in symptom duration between patients with proximal and distal lower limb DVT. This may imply that the duration of the DVT symptoms does not represent a predictive factor for DVT-caused pulmonary embolism.
Introduction
Deep vein thrombosis (DVT) is a common disease with an annual incidence of 0.5-1 per 1000 in the United States. Deep vein thrombosis can lead to the potentially life-threatening complication of pulmonary embolism (PE). 1 With respect to DVT of the lower limbs, it is a wellestablished fact that thrombosis localized above the knee (proximal DVT) carries a significantly higher risk of embolic complications than thrombosis localized below the knee, in the subpopliteal veins (distal DVT). 2 Hence, differentiating between proximal and distal disease would affect decision-making concerning the management and investigation of suspected DVT.
Currently, extensive research is ongoing to determine which clinical clues should be included in a scoring system that could be helpful in stratifying the risk of DVT.
History and risk factors are being investigated as possible indications to help accomplish this. 3 However, more research is needed to clarify which aspects of the patient history obtained in interviews may help in the proximal versus distal disease distinction. 4 One such example could be the duration of the symptoms (swollen leg, muscle pain, etc) reported on anamnesis.
We, therefore, set out to determine whether the duration of the DVT symptoms could correlate to the location of the thrombosis as above or below the knee and thus indirectly predict the risk of PE and affect its management.
Methods

Data Collection and Statistical Analysis
By means of retrospective analysis of the radiology information system (RIS) at our institution, we selected a group of 100 consecutive patients with phlebography-confirmed DVT of the lower extremities, where the duration of the symptoms was known and specified on the radiology examination request and/or on the admission journal.
The group was subsequently divided into subgroups according to the location of the uppermost thrombosis, as indicated on the examination reports, as follows: DVT in the iliac vein, in the femoral vein, in the popliteal vein, in one-deep vein of the leg, or in several deep veins of the leg. Patients with thrombosis in the iliac, femoral, and popliteal veins were considered to have proximal disease and thus grouped in group A. Patients with disease in one or several vessels of the leg were considered to have distal disease and thus grouped in group B.
Symptom duration (expressed in days) was then plotted for the 2 different groups. Symptom duration in each group was compared and tested with the Mann-Whitney U test. Differences were considered statistically significant for P < .05. Data are expressed as mean + standard deviation if not otherwise specified.
Phlebography
All patients included in the study underwent the same examination protocol. Patients were resting in the anti-Trendelenburg position on a fluoroscopy table. A silicone periphery vein catheter was introduced into a vein in the foot in the extremity to be examined. A tourniquet was applied at the ankle to reduce venous flow in the superficial leg veins. Under fluoroscopic surveillance, a total of 100 mL of 300 mg I/mL iodate contrast agent (Optiray) was quickly injected through the vein catheter. Once the deep veins of the leg and thigh were satisfactorily filled with contrast agent, radiographs of the leg, knee, and thigh were obtained in at least 2 projections. When taking radiographs of the iliac vein, the patient was moved from the reverse-Trendelenburg position to a horizontal, supine position to facilitate venous return and improve filling of the iliac vein. Each examination report was signed by 2 radiologists.
Results
Excluded Patients
Only patients whose symptom duration was specified in the examination request and/or the admission journal were included. To reach the pre-determined number of 100 consecutive patients with phlebography-confirmed lower extremities DVT, it was necessary to exclude a total of 24 patients whose symptom duration was unknown or not specified on the request or the admission journal.
However, thrombosis location was as evenly distributed in the group of excluded patients as it was in the included group. This implies that, even if those patients had been included, they would not have altered the results of our study.
Included Patients
Of the 100 consecutive patients with phlebography-confirmed DVT of the lower extremities who were included in the study, 40% were male, while 60% were female. The average age for males was 61.6 years (+16.1). The average age for females was 64.8 years (+ 16.3). The average duration of symptoms for the group as a whole was 6.2 days (+ 6.4), with no differences between males (5.8 + 4.8) or females (6.6 + 7.3).
This group was then divided into 58% with proximal (ie, above the knee) disease, called group A and 42% with distal (ie, below the knee) disease, called group B.
Thrombosis incidence in group A was 15.5% in the iliac vein, 60.4% in the femoral vein, and 24.1% in the popliteal vein.
The incidence of thrombosis in group B was 42.9% in a single leg vessel and 57.1% in multiple leg vessels.
The average number of days with symptoms was 6.31 (+ 6.4, median ¼ 4) for the patients in group A compared to 6.26 days (+ 6.5, median ¼ 4) for patients in group B (Figure 1) .
The Mann-Whitney U test showed no significant difference between the 2 groups (Mann-Whitney U ¼ 1287, N ¼ 100, n1 ¼ 42, n2 ¼ 58, P ¼ .627).
We could therefore find no difference in the duration of symptoms between patients with proximal and distal disease.
Discussion
The primary result of this study is that the duration of the symptoms of DVT does not correlate to its location as demonstrated by phlebography.
Because DVT is such a common disease, the clinician's goal is to find strategies that may allow easy identification of highrisk patients to enable early diagnosis without unnecessary, costly, or potentially harmful tests.
To this end, laboratory tests such as D-dimer, in association with other clinical data, may play an important role in early diagnosis. 5 Moreover, clinical probability tests may help decrease the need for imaging investigations. 6 In an effort to determine the difference in risk factors between proximal and distal DVT, Galanaud and colleagues 7 determined in a retrospective study of a large cohort that distal DVT, which is generally more frequent than proximal DVT, was associated significantly more often with transient risk factors (recent surgery, recent plaster immobilization, recent travel). However, proximal DVT was associated significantly more often with more chronic states (active cancer, congestive heart failure, or respiratory insufficiency, age >75 years).
However, to our knowledge, no study has yet investigated symptom duration per se as a predictor of proximal versus distal disease. Monreal and colleagues 8 have already proven that the incidence of PE in patients with lower limb DVT is not correlated to the duration of the DVT symptoms. Because the location of the thrombosis correlates to the risk of PE, 2 our study underlines that this may be due to the fact that symptom duration does not correlate to thrombosis location.
Thus, this study suggests that proximal DVT, a potentially life-threatening condition, could be present regardless of how short the duration of symptoms, and this finding should be taken into account when deciding on priorities for diagnosis and management.
Unfortunately, information regarding symptom duration is not always easy to obtain and is at times, regrettably, omitted from the examination request. When collecting the series of patients included in our study, we observed this problem in 18% of the patients who underwent phlebography of the lower extremities when DVT was suspected. Those patients were, therefore, excluded from the study group. However, we were able to show that the location of the DVT was evenly distributed even in the excluded patients, which means that this relatively high incidence of excluded patients could not influence the final results.
In this study, we selected only patients whose DVT had been confirmed by phlebography. Phlebography has long been considered the gold standard for the diagnosis of DVT, 9 yielding higher sensitivity than ultrasound, especially in the diagnosis of thrombosis occurring below the knee. 10 This study does not take into account asymptomatic lower limb DVTs, which represent up to one third of total DVTs. Because asymptomatic DVTs are associated with increased mortality in medical patients, 11 some authors advocate screening high-risk patients by means of imaging techniques. In such cases, opinions still vary as to whether compression ultrasound suffices as a screening method. 12, 13 In conclusion, our retrospective study shows that symptom duration does not correlate to the location of the thrombosis in patients with phlebography-diagnosed DVT.
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